Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds

Read Release

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract

Read Release

Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders

Read Release

Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation

Read Release

Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering

Read Release

Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Read Release

Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro

Read Release

Motus GI Announces 1-for-15 Reverse Stock Split

Read Release

Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon

Read Release